Lisa Gillen

Exposure‐Dependent Inhibition of Intestinal and Hepatic CYP3A4 In Vivo by Grapefruit Juice

Maria Luisa Veronese, Lisa Gillen, Joanne Burke et al. · The Journal of Clinical Pharmacology · 2003 · 147 citations

Oral Bioavailability, Gastrointestinal Pharmacology, Pharmacotherapy +20

Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E-3174

Jacqueline B. McCrea, Alastair E. Cribb, Tom Rushmore et al. · Clinical Pharmacology & Therapeutics · 1999 · 73 citations

Biochemistry, Medicine, Bioanalysis +11

A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.

Howard Greenberg, Keith Gottesdiener, Martha Huntington et al. · PubMed · 2000 · 69 citations

Cardiovascular Pharmacology, Pharmacotherapy, Platelet Aggregation +17

Concurrent Administration of the Erythromycin Breath Test (EBT) and Oral Midazolam as In Vivo Probes for CYP3A Activity

Jacqueline B. McCrea, Thomayant Prueksaritanont, Barry J. Gertz et al. · The Journal of Clinical Pharmacology · 1999 · 57 citations

A New Cyclooxygenase‐2 Inhibitor, Rofecoxib (VIOXX®), Did Not Alter the Antiplatelet Effects of Low‐Dose Aspirin in Healthy Volunteers

Howard Greenberg, Keith Gottesdiener, Martha Huntington et al. · The Journal of Clinical Pharmacology · 2000 · 37 citations

Thrombosis, Cardiovascular Disease, Blood Platelet +15